Wearable Devices Ltd. filings document its foreign private issuer reporting for AI-powered touchless sensing wearables, Mudra neural input products and software platforms for XR, mobile and AI applications. Form 6-K reports furnish product announcements, patent notices, financial results and updates on ai6 Labs, Mudra Experience Studio, Mudra Link and Mudra Band.
The filings also cover capital-structure and governance matters, including ordinary shares and tradable warrants, reverse share split disclosure, shareholder meeting results, compensation policy amendments, equity incentive plan share reserves, and incorporation by reference into Form S-8 and Form F-3 registration statements.
Wearable Devices Ltd. registers up to 5,082,873 Ordinary Shares for resale by a selling shareholder; these shares are issuable upon exercise of 5,082,873 New Warrants issued in a private placement. The New Warrants have an exercise price of $1.51 per share and expire five years from issuance.
The company will not receive proceeds from secondary resales by the selling shareholder; the company would receive up to approximately $7.7 million in cash if the New Warrants are exercised in full for cash, assuming exercise in full for cash. Shares outstanding were 6,546,510 as of May 11, 2026; outstanding would be 11,629,383 assuming full cash exercise of all New Warrants.
Wearable Devices Ltd. reports that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a new continuation patent in its “Gesture and Voice-Controlled Interface Device” family. The allowed claims cover a gesture interface device that combines gesture sensors with biopotential sensors to read neural signals and verify users based on personalized gesture signatures.
The technology is designed to enable biometric authentication for secure payments, user detection, and authorization of sensitive actions on the company’s AI‑powered voice‑and‑gesture control platform. Management describes this allowance as strengthening its intellectual property strategy and reinforcing the Mudra platform’s role in AR/VR, enterprise access control, and smart environments.
Wearable Devices Ltd. entered a warrant inducement transaction with an institutional investor, raising approximately $5.0 million in gross cash proceeds through the cash exercise of existing warrants at a reduced price of $1.73 per ordinary share.
In return, the company issued new unregistered warrants to purchase up to 5,082,873 ordinary shares at an exercise price of $1.51 per share, exercisable immediately for five years. The company plans to use the net proceeds for working capital and general corporate purposes and agreed to register the resale of the new warrant shares and observe a 30‑day restriction on additional issuances, new registrations, and variable rate transactions, subject to stated exceptions.
Wearable Devices Ltd. director Bachar Eli filed an initial ownership report showing direct holdings in both ordinary shares and stock options. He reports 37,884 Ordinary Shares held directly, plus stock options over 768 Ordinary Shares at an exercise price of $0.7200 per share expiring on November 27, 2027, and options over 83 Ordinary Shares at an exercise price of $316.8000 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives, including 7,500 Ordinary Shares issuable from 2,500 restricted share units vesting through October 10, 2028, and 28,333 Ordinary Shares issuable from other restricted share units vesting in 34 monthly installments through January 1, 2029.
Wearable Devices Ltd. Chief Executive Officer Asher Dahan filed an initial Form 3, reporting his current equity stake in the company. He directly holds 72,708 Ordinary Shares, reflecting his existing ownership position as of the filing date.
In addition, Dahan holds stock options over 125 Ordinary Shares at an exercise price of $316.80 per share expiring on November 30, 2033, and options over 208 Ordinary Shares at an exercise price of $104.16 per share expiring on September 26, 2034. Footnotes state that his holdings include 6,250 Ordinary Shares issuable upon vesting of RSUs in monthly installments through September 10, 2026, and 47,222 Ordinary Shares issuable upon vesting of RSUs in monthly installments through January 1, 2029, with each RSU representing one Ordinary Share.
Wearable Devices Ltd. director and executive officer Wagner Guy filed an initial ownership report showing his equity position in the company. He directly holds 74,583 Ordinary Shares, along with restricted share units that can convert into additional shares over time as they vest.
The filing also lists two stock option awards. One option covers 125 Ordinary Shares at an exercise price of 316.8000, vesting partly on August 23, 2024 and then in monthly installments. A second option covers 208 Ordinary Shares at an exercise price of 104.1600, vesting from August 15, 2025 in monthly installments. The document records these as holdings, not new market purchases or sales.
Wearable Devices Ltd. filed an initial ownership report for Chief Technology Officer Langer Leeor Jacob. He directly holds 72,917 Ordinary Shares and stock options to acquire 125 additional Ordinary Shares at an exercise price of 316.8 per share, expiring on August 23, 2033.
The filing notes 6,250 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,042 shares through September 10, 2026, and 47,222 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,389 shares through January 1, 2029.
Wearable Devices Ltd. executive Remez Offir has filed an initial Form 3 showing his equity holdings in the company. The filing reports direct ownership of 25,417 Ordinary Shares as of the reporting date, establishing his baseline stake as Executive VP of Business Development.
Offir also holds stock options over 571 Ordinary Shares at an exercise price of $0.72 per share expiring on November 1, 2031, and options over 83 Ordinary Shares at an exercise price of $316.80 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives through restricted share units: 2,500 Ordinary Shares vesting in equal monthly installments of 417 shares through September 10, 2026, and 16,528 Ordinary Shares vesting in equal monthly installments of 486 shares through January 1, 2029, with each RSU convertible into one Ordinary Share.